Eli Lilly & Co. (LLY) News and Global Pharmaceutical Innovation Updates
1,117.35
10.27
0.93 %
At close
06/24
USD
Daily range
1101.01
1132.54
1132.54
Weekly range
1079.22
1132.54
1132.54
Eli Lilly stock consolidates near $1,100 with continued bullish momentum supported by MACD: weekly forecast
Eli Lilly and Company (LLY) ended the week at $1,106.92, marking a gain of $7.44 or 0.59% over the last seven days. The price remains firmly above the weekly MA-20 at ...
Eli Lilly expands AI drug discovery investment to diversify beyond weight-loss franchise
Rising cash flow from Eli Lilly's blockbuster obesity and diabetes medicines is funding a broader push into artificial intelligence and biotech deals as the company prepares for patent expiries in ...
Eli Lilly expands dealmaking in pain drugs as Broadcom insider buy signals confidence
Investors are rotating across sectors after a sharp technology rally, while healthcare and financial stocks draw attention alongside falling oil prices and steady rate expectations. In that ...
Eli Lilly stock edges lower while buyers defend $1,111 support: weekly analysis
Eli Lilly and Company (LLY) is currently trading at $1,124.43, maintaining a strong bullish profile well above the weekly MA-20 ($1,003.56), MA-50 ($933.13), and MA-200 ...
Eli Lilly shares dip amid rising selling pressure
Eli Lilly and Company (LLY) is trading at $1,135.05, above the 20-day ($1,079.18), 50-day ($992.89), and 200-day ($956.36) moving averages. Today’s price is down 2.13%, closing near the low end ...
Why is Eli Lilly stock up today?
Eli Lilly and Company (LLY) is currently trading at $1,160.25, up $23.88, or 2.10% on the day. The asset remains well above its 20-day ($1,071.94), 50-day ($988.08), and 200-day ($954.04) moving ...
+2.53% for Eli Lilly stock as 113% earnings surge supports growth outlook
Eli Lilly (LLY) stock is trading at $1,165.09 after climbing 2.53% intraday, with the price holding well above its key moving ...
U.S. employers plan to cut GLP-1 obesity drug coverage as usage lifts benefit costs
Rising use of obesity medicines is prompting some large U.S. employers to reconsider whether they will keep paying for GLP-1 treatments in 2027. Lower prices for Novo Nordisk's Wegovy and Eli ...
LLY stock supported by clinical pipeline expansion and licensing deal optimism: weekly analysis
Eli Lilly and Company (LLY) shares are currently trading at $1,158.44, marking a robust advance of $38.39, or 3.10%, for the week. The price has established a clear ...
Why is Eli Lilly stock up today?
Eli Lilly and Company (LLY) is trading well above all major moving averages, with the current price of $1,156.26 standing above the 20-day ($1,045.74), 50-day ($972.74), and 200-day ($947.52) ...
Johnson & Johnson charts signal potential pharma breakout as sector momentum strengthens
Pharmaceutical shares are gaining leadership within healthcare as sector momentum improves against the broader market. That shift is supporting expectations that other large-cap drugmakers could ...
Novo Nordisk and Eli Lilly expand obesity pill push ahead of Medicare coverage
Competition in the obesity drug market is intensifying as Novo Nordisk and Eli Lilly roll out GLP-1 pills alongside their established injectable treatments. The rivalry is taking on added ...
Weight-loss drug updates at diabetes conference propel Eli Lilly stock higher
Eli Lilly and Company (LLY) stock is trading at $1,174.44, marking a daily rise of 4.86%. The price remains above its key moving averages, highlighting strong upward ...
Eli Lilly stock rises as Ascidian Therapeutics partnership for genetic kidney medicines announced
Eli Lilly and Company (LLY) stock is trading at $1,160.01, up 3.25% for the day and extending gains after opening with an upside gap. The price remains well above its ...
What is behind Eli Lilly stock's recent gain in value today
Eli Lilly and Company (LLY) is trading well above its 20-day ($1,038.40), 50-day ($968.63), and 200-day ($945.43) simple moving averages, confirming strong bullish momentum across short, medium, ...
Eli Lilly stock price forecast: $1,155.70 resistance as LLY advances 4.39%
Eli Lilly and Company (LLY) stock is trading at $1,128.52, having risen 4.39% on the day. The price currently sits above its key moving averages, highlighting positive ...
GE Vernova fails to end Vineyard Wind work mandate in Massachusetts dispute
A Massachusetts court keeps pressure on GE Vernova to stay on the Vineyard Wind project as the companies fight over payments and turbine support. The ruling preserves work on New England's largest ...
Selling pressure pushes Eli Lilly stock lower in today's trading
Eli Lilly and Company (LLY) is trading at $1,077.25 and ended the day down 2.38%. The stock remains well above its 20-, 50-, and 200-day moving averages, confirming a robust uptrend across short, ...
LLY shares consolidate within recent $1,059–$1,132 range as buyers maintain control: weekly forecast
Eli Lilly and Company (LLY) is trading at $1,096.25, holding well above its weekly MA-20 at $991.40, MA-50 at $911.88, and MA-200 at $693.53. Over the last week, LLY ...
Eli Lilly stock price forecast: $999.66 support in focus as LLY drops 3.05%
Eli Lilly and Company (LLY) stock is trading at $1,093.63, marking a daily decline of 3.05%. The price remains well above its key moving averages, reflecting resilience ...
Why is Eli Lilly stock down today?
Eli Lilly and Company (LLY) is currently trading at $1,095.37, down $32.72 or 2.90% for the day. The stock remains well above its 20-day ($1,007.90), 50-day ($950.70), and 200-day ($935.10) moving ...
